Related Funds
Funds with similar focus
Fund Name | Location |
Al Serkal Group | Dubai, United Arab Emirates |
Chart Industries | Ohio, Ohio City, United States |
China Fortune Securities | China, Guangdong, Shenzhen |
Cronus Ventures | Bellevue, United States, Washington |
Daum Communications | Cheju-do, Jeju, South Korea |
Encavis | Germany, Hamburg |
Hadean Ventures | Norway, Oslo |
Horizon Group | - |
Industrial Bank | China, Foochow, Fujian |
Jostens | Minneapolis, Minnesota, United States |
Konsortium | Bayern, Germany, Gersthofen |
Kyosemi | Japan, Kyoto, Kyoto Prefecture |
Patriot Financial Partners | Pennsylvania, Philadelphia, United States |
Sasken Communication Technologies | Bengaluru, India, Karnataka |
SDIC Unity Capital | Beijing, Beijing, China |
The Scoular Company | Nebraska, Omaha, United States |
Viewpoint Investment Partners | - |
Warburton Group | - |
Yamcom Holdings BV | Afula, Israel, North District |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Ionpath | $18M | 24 Sep 2020 | California, United States | ||
TARA Biosystems | $10M | 23 Jun 2020 | New York, New York, United States | ||
Filtricine | $5M | 29 Oct 2018 | San Jose, California, United States | ||
TARA Biosystems | $9M | 16 Oct 2017 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Ionpath | $18M | 24 Sep 2020 | California, United States | ||
TARA Biosystems | $10M | 23 Jun 2020 | New York, New York, United States | ||
Filtricine | $5M | 29 Oct 2018 | San Jose, California, United States | ||
TARA Biosystems | $9M | 16 Oct 2017 | New York, United States |